Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

Thakore, Pratiksha I, D'Ippolito, Anthony M, Song, Lingyun, Safi, Alexias, Shivakumar, Nishkala K, Kabadi, Ami M, Reddy, Timothy E, Crawford, Gregory E +1 more·2015·Nature Methods

Cited by (1,000)

Items 101–200 of 1,000

  1. Dead Cas Systems: Types, Principles, and Applications
    Sergey Brezgin, Anastasiya Kostyusheva, Dmitry S. Kostyushev, Vladimir Chulanov · 2019 · International Journal of Molecular Sciences
  2. CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine
    Filipe V. Jacinto, Wolfgang Link, Bibiana I. Ferreira · 2020 · Journal of Cellular and Molecular Medicine
  3. Characterization of noncoding regulatory DNA in the human genome
    Ran Elkon, Reuven Agami · 2017 · Nature Biotechnology
  4. Engineering cell signaling using tunable CRISPR–Cpf1-based transcription factors
    Yuchen Liu, Jinghong Han, Zhicong Chen, Hanwei Wu, Hongsong Dong, Guohui Nie · 2017 · Nature Communications
  5. Epigenome editing technologies for discovery and medicine
    Sean R. McCutcheon, Dahlia Rohm, Nahid Iglesias, Charles A. Gersbach · 2024 · Nature Biotechnology
  6. Nested epistasis enhancer networks for robust genome regulation
    Xueqiu Lin, Yanxia Liu, Shuai Liu, Xiang Zhu, Lingling Wu, Yanyu Zhu, Dehua Zhao, Xiaoshu Xu, Augustine G. Chemparathy, Haifeng Wang et al. · 2022 · Science
  7. Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis
    Yoshiharu Muto, Eryn E. Dixon, Yasuhiro Yoshimura, Hao Wu, Kohei Omachi, Nicolas Ledru, Parker C. Wilson, Andrew J. King, N. Eric Olson, Marvin G. Gunawan et al. · 2022 · Nature Communications
  8. Plant Genome Editing and the Relevance of Off-Target Changes
    Nathaniel D. Graham, Gunvant Patil, David M. Bubeck, Raymond C. Dobert, Kevin C. Glenn, Annie T. Gutsche, Sandeep Kumar, John A. Lindbo, Luis Maas, Gregory D. May et al. · 2020 · PLANT PHYSIOLOGY
  9. Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers
    Qinglan Li, Xiang Lin, Yali Yu, Lin Chen, Qi‐Xin Hu, Meng Chen, Nan Cao, Chen Zhao, Chen-Yu Wang, Cheng‐Wei Huang et al. · 2021 · Nature Communications
  10. Engineering of temperature- and light-switchable Cas9 variants
    Florian Martin Richter, Ines Fonfara, Boris Bouazza‐Arostegui, Charlotte Helene Schumacher, Majda Bratovič, Emmanuelle Charpentier, Andreas Möglich · 2013 · Nucleic Acids Research
  11. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing
    Charlene Babra Waryah, Colette Moses, Mahira Arooj, Pilar Blancafort · 2018 · Methods in molecular biology
  12. Massively parallel discovery of human-specific substitutions that alter enhancer activity
    Severin Uebbing, Jake Gockley, Steven K. Reilly, Acadia A. Kocher, Evan T. Geller, Neeru Gandotra, Curt Scharfe, Justin L. Cotney, James P. Noonan · 2020 · Proceedings of the National Academy of Sciences
  13. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells
    Rita Vassena, Björn Heindryckx, Rubén Peco, Guido Pennings, Ángel Raya, Karen Sermon, Anna Veiga · 2016 · Human Reproduction Update
  14. Engineering cell sensing and responses using a GPCR-coupled CRISPR-Cas system
    Nathan H. Kipniss, P.C. Dave P. Dingal, Timothy R. Abbott, Yuchen Gao, Haifeng Wang, Antonia A. Dominguez, Louai Labanieh, Lei S. Qi · 2017 · Nature Communications
  15. Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor α-Bound Enhancers
    Julia B. Carleton, Kristofer C. Berrett, Jason Gertz · 2017 · Cell Systems
  16. CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases
    Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Chunjie Huang, Zhou Ao, Muhammad Jamal, Ali Zohaib, Farhan Ahmed Khan, Muthia Raihana Hakim, Zhang ShuJun · 2016 · Oncotarget
  17. Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
    Mareike Daniela Hoffmann, Sabine Aschenbrenner, Stefanie Große, Kleopatra Rapti, Claire Domenger, Julia Fakhiri, Manuel Mastel, Kathleen Börner, Roland Eils, Dirk Grimm et al. · 2019 · Nucleic Acids Research
  18. Sharpening the Molecular Scissors: Advances in Gene-Editing Technology
    Mike Broeders, Pablo Herrero-Hernandez, Martijn P. T. Ernst, Ans T. van der Ploeg, W.W.M. Pim Pijnappel · 2019 · iScience
  19. Convergence of coronary artery disease genes onto endothelial cell programs
    Gavin R. Schnitzler, Helen Y. Kang, Shi Fang, Ramcharan Singh Angom, Vivian S. Lee-Kim, X. Rosa Ma, Ronghao Zhou, Tony Zeng, Katherine Guo, Martin S. Taylor et al. · 2024 · Nature
  20. The CRISPR /Cas revolution reaches the RNA world: Cas13, a new Swiss Army knife for plant biologists
    Felix Wolter, Holger Puchta · 2018 · The Plant Journal
  21. Drugging the epigenome in the age of precision medicine
    Taylor Feehley, Charles W. O’Donnell, John D. Mendlein, Mahesh Karande, Thomas McCauley · 2023 · Clinical Epigenetics
  22. Deciphering the Emerging Complexities of Molecular Mechanisms at GWAS Loci
    Maren E. Cannon, Karen L. Mohlke · 2018 · The American Journal of Human Genetics
  23. Identify Key Sequence Features to Improve CRISPR sgRNA Efficacy
    Lei Chen, Shaopeng Wang, Yuhang Zhang, Jiarui Li, Zhihao Xing, Jialiang Yang, Tao Huang, Yu‐Dong Cai · 2017 · IEEE Access
  24. dCas9: A Versatile Tool for Epigenome Editing
    Daan J.W. Brocken, Mariliis Tark‐Dame, Remus Thei Dame · 2017 · Current Issues in Molecular Biology
  25. Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates
    Thurtle‐Schmidt, Deborah M., Lo, Te‐Wen · 2018 · Biochemistry and Molecular Biology Education
  26. Emerging Gene Therapies for Genetic Hearing Loss
    Hena Ahmed, Olga Shubina-Oleinik, Jeffrey R. Holt · 2017 · Journal of the Association for Research in Otolaryngology
  27. Design principles of 3D epigenetic memory systems
    Jeremy A. Owen, Dino Osmanović, Leonid A. Mirny · 2023 · Science
  28. CRISPR technologies for stem cell engineering and regenerative medicine
    Mu‐Nung Hsu, Yu‐Han Chang, Vu Anh Truong, Po‐Liang Lai, Thị Kieu Nuong Nguyen, Yu‐Chen Hu · 2019 · Biotechnology Advances
  29. Emerging roles for long noncoding RNAs in skeletal biology and disease
    Nguyen P.T. Huynh, Britta A. Anderson, Farshid Guilak, Audrey McAlinden · 2016 · Connective Tissue Research
  30. Pre-established Chromatin Interactions Mediate the Genomic Response to Glucocorticoids
    Anthony M. D’Ippolito, Ian C. McDowell, Alejandro Barrera, Linda K. Hong, Sarah M. Leichter, Luke C. Bartelt, Christopher M. Vockley, William H. Majoros, Alexias Safi, Lingyun Song et al. · 2018 · Cell Systems
  31. Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine Signaling
    Gao, Jinhang, Wei, Bo, Liu, Mengfei, Hirsova, Petra, Sehrawat, Tejasav S., Cao, Sheng, Hu, Xiao, Xue, Fei, Yaqoob, Usman, Kang, Ningling et al. · 2021 · Hepatology
  32. Genomic Resolution of DLX-Orchestrated Transcriptional Circuits Driving Development of Forebrain GABAergic Neurons
    Susan Lindtner, Rinaldo Catta-Preta, Hua Tian, Linda Su-Feher, James D. Price, Diane E. Dickel, Vanille Juliette Greiner, Shanni N. Silberberg, Gabriel L. McKinsey, Michael T. McManus et al. · 2019 · Cell Reports
  33. A universal deep-learning model for zinc finger design enables transcription factor reprogramming
    David M. Ichikawa, Osama Abdin, Nader Alerasool, Manjunatha Kogenaru, April L. Mueller, Han Wen, David O. Giganti, Gregory W. Goldberg, Samantha Adams, Jeffrey M. Spencer et al. · 2023 · Nature Biotechnology
  34. Dynamic reprogramming of H3K9me3 at hominoid-specific retrotransposons during human preimplantation development
    Hanwen Yu, Manqi Chen, Yuanlang Hu, Songbang Ou, Yu Xiu, Shiqi Liang, Niannian Li, Mingzhu Yang, Xuhui Kong, Chuanbo Sun et al. · 2022 · Cell stem cell
  35. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity
    Vanja Tadić, Goran Josipović, Vlatka Zoldoš, Aleksandar Vojta · 2019 · Methods
  36. Crosstalk between RNA m6A and DNA methylation regulates transposable element chromatin activation and cell fate in human pluripotent stem cells
    Tongyu Sun, Yueyuan Xu, Yu Xiang, Jianhong Ou, Erik J. Soderblom, Yarui Diao · 2023 · Nature Genetics
  37. CRISPR/Cas9 mediated targeting of multiple genes in Dictyostelium
    Ryoya Sekine, Takefumi Kawata, Tetsuya Muramoto · 2018 · Scientific Reports
  38. Epigenome engineering: new technologies for precision medicine
    Agustin Sgro, Pilar Blancafort · 2020 · Nucleic Acids Research
  39. Tumour-wide RNA splicing aberrations generate actionable public neoantigens
    Darwin W. Kwok, Nicholas O. Stevers, Iñaki Etxeberría, Takahide Nejo, Maggie Colton Cove, Lee H. Chen, Jangham Jung, Kaori Okada, Senthilnath Lakshmanachetty, Marco Gallus et al. · 2025 · Nature
  40. Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications
    Didovyk, Andriy, Borek, Bartłomiej, Tsimring, Lev, Hasty, Jeff · 2016 · Current Opinion in Biotechnology
  41. Gene therapy clinical trials worldwide to 2023—an update
    S. Ginn, M. Mandwie, Ian E. Alexander, Michael L. Edelstein, Mohammad R. Abedi · 2024 · Journal of Gene Medicine
  42. CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments
    Niloofar Farhang, Jonathan M. Brunger, J. Stover, Pratiksha I. Thakore, Brandon D. Lawrence, F. Guilak, C. Gersbach, L. Setton, R. Bowles · 2017 · Tissue Engineering. Part A
  43. BET bromodomain proteins regulate enhancer function during adipogenesis
    Jonathan D. Brown, Zachary B. Feldman, Sean P. Doherty, Jaime M. Reyes, Peter B. Rahl, Charles Y. Lin, Quanhu Sheng, Qiong Duan, Alexander Joel Federation, Andrew L. Kung et al. · 2018 · Proceedings of the National Academy of Sciences
  44. Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System
    Nina Xie, Yafang Zhou, Qiying Sun, Beisha Tang · 2018 · Stem Cells International
  45. A comparison of experimental assays and analytical methods for genome-wide identification of active enhancers
    Yao Li, Jin Hua Liang, Abdullah Ozer, Alden King-Yung Leung, John T. Lis, Haiyuan Yu · 2022 · Nature Biotechnology
  46. Epigenome editing strategies for the functional annotation of CTCF insulators
    Tarjan, Daniel R., Flavahan, William A., Bernstein, Bradley E. · 2019 · Nature Communications
  47. Illuminating the noncoding genome in cancer
    Xiaoyang Zhang, Matthew M. Meyerson · 2020 · Nature Cancer
  48. Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
    Samah W. Awwad, Almudena Serrano-Benítez, John Christopher Thomas, Vipul Gupta, Stephen P. Jackson · 2023 · Nature Reviews Molecular Cell Biology
  49. Beyond Native Cas9: Manipulating Genomic Information and Function
    Hitoshi Mitsunobu, Jun Teramoto, Keiji Nishida, Akihiko Kondo · 2017 · Trends in biotechnology
  50. Genome editing comes of age
    Jin‐Soo Kim · 2016 · Nature Protocols
  51. Primate-restricted KRAB zinc finger proteins and target retrotransposons control gene expression in human neurons
    Priscilla Turelli, Christopher J. Playfoot, Dephine Grun, Charlène Raclot, Julien Pontis, Alexandre Coudray, Christian Wandall Thorball, Julien Duc, Eugenia V. Pankevich, Bart Deplancke et al. · 2020 · Science Advances
  52. Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes
    Seok‐Man Ho, Brigham J. Hartley, Erin K. Flaherty, Prashanth Rajarajan, Rawan Abdelaal, Ifeanyi Obiorah, Natalie Barretto, Hamza Muhammad, Hemali P. Phatnani, Schahram Akbarian et al. · 2017 · Stem Cell Reports
  53. Next-generation metabolic engineering approaches towards development of plant cell suspension cultures as specialized metabolite producing biofactories
    Sagar S. Arya, James Edward Rookes, David Miles Cahill, Sangram Keshari Lenka · 2020 · Biotechnology Advances
  54. LncRNAs associated with glioblastoma: From transcriptional noise to novel regulators with a promising role in therapeutics
    Bhupender Yadav, Sonali Pal, Yury Rubstov, Akul Goel, Manoj Garg, Marat S. Pavlyukov, Amit Kumar Pandey · 2021 · Molecular Therapy — Nucleic Acids
  55. Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma
    Matthew Louis Hedberg, Corbett T. Berry, Ata S. Moshiri, Yan Xiang, Christopher J. Yeh, Cem Atillasoy, Brian C. Capell, John T. Seykora · 2022 · International Journal of Molecular Sciences
  56. Trithorax dependent changes in chromatin landscape at enhancer and promoter regions drive female puberty
    Carlos A. Toro, Hollis Wright, Carlos Francisco Aylwin, Sergio R. Ojeda, Alejandro Lomniczi · 2017 · Nature Communications
  57. Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics
    Lopes, Rui, Prasad, Megana K. · 2024 · Frontiers in Bioengineering and Biotechnology
  58. Genome and epigenome engineering CRISPR toolkit for in vivo modulation of cis-regulatory interactions and gene expression in the chicken embryo
    Ruth M. Williams, U. Senanayake, Mara Artibani, Gunes Taylor, D. Wells, A. Ahmed, T. Sauka-Spengler · 2018 · Development
  59. Scalable Functional Assays for the Interpretation of Human Genetic Variation
    Daniel R. Tabet, Victoria Nicole Parikh, Prashant Mali, Frederick P. Roth, Melina Claussnitzer · 2022 · Annual Review of Genetics
  60. Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction
    Ali Ahmed Rabaan, Hajir AlSaihati, Rehab Bukhamsin, Muhammed Adnan Bakhrebah, Majed Saeed Nassar, Abdulmonem Ali Alsaleh, Yousef N. Alhashem, Ammar Y. Bukhamseen, Khalil Al-Ruhimy, Mohammed H. Alotaibi et al. · 2023 · Current Oncology
  61. Genetic and epigenetic control of gene expression by CRISPR–Cas systems
    Albert Lo, Lei S. Qi · 2017 · F1000Research
  62. Epigenetics applied to psychiatry: Clinical opportunities and future challenges
    Lara Kular, Sonia Kular · 2018 · Psychiatry and Clinical Neurosciences
  63. Optimization of CRISPR/Cas9 genome editing for loss-of-function in the early chick embryo
    Shashank Gandhi, Michael L. Piacentino, Felipe Monteleone Vieceli, Marianne E. Bronner-Fraser · 2017 · Developmental Biology
  64. Transcriptional control by enhancers and enhancer RNAs
    Michael W. Lewis, Li Shen, Hector L. Franco · 2019 · Transcription
  65. Precision Modulation of Neurodegenerative Disease-Related Gene Expression in Human iPSC-Derived Neurons
    Sabrina M. Heman-Ackah, Andrew Roger Bassett, Matthew J. A. Wood · 2016 · Scientific Reports
  66. Genome-scale CRISPR pooled screens
    Neville E. Sanjana · 2016 · Analytical Biochemistry
  67. Next stop for the CRISPR revolution: RNA‐guided epigenetic regulators
    Suhani Vora, Marcelle L. Tuttle, Jenny Yeuk‐Ki Cheng, George McDonald Church · 2016 · FEBS Journal
  68. Targeted transcriptional modulation with type I CRISPR–Cas systems in human cells
    Adrian Pickar‐Oliver, Joshua B. Black, Mae M. Lewis, Kevin J. Mutchnick, Tyler S. Klann, Kylie A. Gilcrest, Madeleine J. Sitton, Christopher E. Nelson, Alejandro Barrera, Luke C. Bartelt et al. · 2019 · Nature Biotechnology
  69. CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review
    Nagaraj Bharathkumar, Sunil Abraham, Prabhakar Meera, Sam Aksah, K. Muthu, Konda Mani Saravanan, Thirunavukarasou Anand · 2021 · Molecular Biotechnology
  70. Epigenetics of Early Cardiometabolic Disease: Mechanisms and Precision Medicine
    Andrea Baccarelli, José María Ordovás · 2023 · Circulation Research
  71. Applications of CRISPR Genome Engineering in Cell Biology
    Fangyuan Wang, Lei S. Qi · 2016 · Trends in Cell Biology
  72. ZEB2 Shapes the Epigenetic Landscape of Atherosclerosis
    Paul P. Cheng, Robert C. Wirka, Shoa L. Clarke, Quanyi Zhao, Ramendra Krishna Kundu, Trieu Nguyen, Surag Nair, Disha Sharma, Hyun-Jung Kim, Huitong Shi et al. · 2022 · Circulation
  73. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing
    Henriette O’Geen, Markéta Tomková, Jacquelyn A Combs, Emma Tilley, David Jay Segal · 2022 · Nucleic Acids Research
  74. Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics
    Ana P. Teixeira, Martin Fussenegger · 2023 · Advanced Science
  75. From biomarkers to therapeutic targets—the promises and perils of long non-coding RNAs in cancer
    Tony Gutschner, Georg Richtig, Monika Haemmerle, Martin Pichler · 2017 · Cancer and Metastasis Reviews
  76. SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression
    Guojun Hou, Isaac T. W. Harley, Xiaoming Lu, Tian Zhou, Ning Xu, Chao Yao, Yuting Qin, Ye Ouyang, Jianyang Ma, Xinyi Zhu et al. · 2021 · Nature Communications
  77. Drug-tunable multidimensional synthetic gene control using inducible degron-tagged dCas9 effectors
    Dirk A. Kleinjan, Caroline Wardrope, Si Nga Sou, Susan J. Rosser · 2017 · Nature Communications
  78. The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia
    Shi Hao Tan, Wei Zhong Leong, Phuong Cao Thi Ngoc, Tze King Tan, Fatima Carla Bertulfo, Mei Chee Lim, Ömer An, Zhenhua Li, Allen Eng Juh Yeoh, Melissa J. Fullwood et al. · 2019 · Blood
  79. Beyond the Exome: The Non-coding Genome and Enhancers in Neurodevelopmental Disorders and Malformations of Cortical Development
    Elena Perenthaler, Soheil Yousefi, Eva Niggl, Tahsin Stefan Barakat · 2019 · Frontiers in Cellular Neuroscience
  80. Applications of CRISPR-Cas systems in lactic acid bacteria
    Avery Roberts, Rodolphe Barrangou · 2020 · FEMS Microbiology Reviews
  81. Novel epigenetic therapeutic strategies and targets in cancer
    Quratulain Babar, Ayesha Saeed, Tanveer Ahmad Tabish, Sabrina Pricl, Helen Elizabeth Townley, Nanasaheb D. Thorat · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  82. CRISPR-Cas9 technology: applications and human disease modelling
    Raúl Torres-Ruiz, Sandra Rodríguez · 2016 · Briefings in Functional Genomics
  83. Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
    Julian Musa, Florencia Cidre‐Aranaz, Marie-Ming Aynaud, Martin F. Orth, Maximilian M. L. Knott, Olivier Mirabeau, Gal Mazor, Mor Varon, Tilman L. B. Hölting, Sandrine Grossetête et al. · 2019 · Nature Communications
  84. CRISPR-Based Epigenome Editing: Mechanisms and Applications
    Shaima M Fadul, Aleeza Arshad, Rashid Mehmood · 2023 · Epigenomics
  85. Dynamic evolution of regulatory element ensembles in primate CD4+ T cells
    Charles G. Danko, Lauren A. Choate, Brooke A. Marks, Edward J. Rice, Zhong Wang, Tinyi Chu, Andre L. Martins, Noah Dukler, Scott Alexander Coonrod, Elia D. Tait Wojno et al. · 2018 · Nature Ecology & Evolution
  86. Modulating the expression of long non‐coding RNAs for functional studies
    Siyuan John Liu, Daniel A. Lim · 2018 · EMBO Reports
  87. Genome engineering: a new approach to gene therapy for neuromuscular disorders
    Christopher E. Nelson, Jacqueline N. Robinson-Hamm, Charles A. Gersbach · 2017 · Nature Reviews Neurology
  88. Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1
    Ying Ying, Yejun Wang, Xiaoyan Huang, Yanmei Sun, Junbao Zhang, Meiqi Li, Junhui Zeng, Maolin Wang, Wenjun Xiao, Lan Zhong et al. · 2019 · Oncogene
  89. Successful delivery of large-size CRISPR/Cas9 vectors in hard-to-transfect human cells using small plasmids
    Jonas Nørskov Søndergaard, Keyi Geng, Christian Sommerauer, Ionut Atanasoai, Xiushan Yin, Claudia Kutter · 2020 · Communications Biology
  90. Epigenome editing of microsatellite repeats defines tumor-specific enhancer functions and dependencies
    Gaylor Boulay, Angela Volorio, Sowmya Iyer, Liliane C. Broye, Ivan Stamenkovic, Nicolò Riggi, Miguel N. Rivera · 2018 · Genes & Development
  91. Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring
    Sugandha Bhatia, James H. Monkman, Alan Kie Leong Toh, Shivashankar Hiriyur Nagaraj, Erik W. Thompson · 2017 · Biochemical Journal
  92. Applying multi‐omics toward tumor microbiome research
    Nan Zhang, Shruthi Kandalai, Xiaozhuang Zhou, Farzana Hossain, Qingfei Zheng · 2023 · iMeta
  93. Epigenetic editing by CRISPR/dCas9 in Plasmodium falciparum
    Bo Xiao, Shigang Yin, Yang Hu, Maoxin Sun, Jieqiong Wei, Zhenghui Huang, Yuhao Wen, Xueyu Dai, Huiling Chen, Jianbing Mu et al. · 2018 · Proceedings of the National Academy of Sciences
  94. Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
    Shuquan Rao, Yao Yao, Daniel E. Bauer · 2021 · Genome Medicine
  95. Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics
    Eliza C. Miller, Ashley Wilczek, Natalie Ann Bello, Sarah E. Tom, Ronald J. Wapner, Yousin Suh · 2021 · Ageing Research Reviews
  96. Targeted epigenomic editing ameliorates adult anxiety and excessive drinking after adolescent alcohol exposure
    Bohnsack, John Peyton, Zhang, Huaibo, Wandling, Gabriela M., He, Donghong, Kyzar, Evan J., Lasek, Amy W., Pandey, Subhash C. · 2022 · Science Advances
  97. Gene-Specific Targeting of DNA Methylation in the Mammalian Genome
    Arthur Urbano, Jim Smith, Robert J. Weeks, Aniruddha Chatterjee · 2019 · Cancers
  98. CRISPR-Cas-Based Engineering of Probiotics
    Ling Liu, Shimaa Elsayed Helal, Nan Peng · 2023 · BioDesign Research
  99. Targeting PIKfyve-driven lipid metabolism in pancreatic cancer
    Caleb Cheng, Jing Hu, R. Mannan, Tongchen He, Rupam Bhattacharyya, Brian Magnuson, Jasmine P. Wisniewski, Sydney Peters, S. Karim, David J. MacLean et al. · 2025 · Nature
  100. Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners’ Perspective
    Kenneth M. Comess, Shaun M. McLoughlin, Jon A. Oyer, Paul L. Richardson, Henning Stöckmann, Anil Vasudevan, Scott E. Warder · 2018 · Journal of Medicinal Chemistry